Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy

Table 6 Comparison of FIB-4 index between groups a and b from baseline to 144 wk

	Group a (n = 120)	Group b (n = 58)	P value
0 wk	1.56 ± 1.14	1.27 ± 0.99	0.11
144 wk	1.12 ± 0.81	1.10 ± 0.78	0.89
0-144 wk	0.44 ± 0.99	0.17 ± 0.98	0.09

Group a: HBV DNA was undetectable at week 144; Group b: HBV DNA was still detectable at week 144.